[Mixed connective tissue disease].
Tanaka
K
K
Department of Neurology, Brain Research Institute, Niigata University.
Tanaka
M
M
D000925:Anticoagulants / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006680:HLA Antigens; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008775:Methylprednisolone / Q000008:administration & dosage; D008947:Mixed Connective Tissue Disease / Q000209:etiology / Q000503:physiopathology; D011379:Prognosis; D020551:Pulse Therapy, Drug; D017412:Ribonucleoprotein, U1 Small Nuclear / Q000276:immunology
D000925:Anticoagulants; D006680:HLA Antigens; D007166:Immunosuppressive Agents; D017412:Ribonucleoprotein, U1 Small Nuclear; D008775:Methylprednisolone